The new patent regime is challenging the Indian biopharm industry to transition from generics to novel products.
Rakhi Rashmi
Advertisement
Research Scholar at Jawaharlal Nehru University
Articles by Rakhi Rashmi
Advertisement
Latest Updated Articles
Advertisement
Advertisement